Article by Sam Riches, Growth Op
Former NHL enforcer Ryan Vandenbussche, who played alongside some of the game’s greats like Wayne Gretzky, Sidney Crosby and Mario Lemieux, founded the cannabis company New Leaf Canada in 2010.
After fighting more than 100 times over the course of his hockey career and dealing with more than 20 concussions, Vandenbussche wanted to explore alternative therapies for treating physical and mental health. Now he’s expanding that focus to include psilocybin.
New Leaf has received approval from Health Canada to allow its wholly-owned subsidiary Psirenity to begin construction of a psilocybin research facility at its Norfolk County location.
The Controlled Drug and Substances Act licensed facility will be focused on psilocybin and psilocin production, as well as strain development, extraction, and the formulation of investigational products for future clinical trials. The facility will also supply the drugs needed for Psirenity’s Health and Wellness Therapy Clinic.
Chris McCullough, CEO of Psirenity, said the company is expected to begin construction on the new facility within the next 60 days.
“It will establish a real footprint in Canada for Psirenity’s psilocybin and psilocin research once we receive CDSA licensing approval from Health Canada. Our work will hopefully lead to vital, new treatments in psychedelic-enhanced mental health, allowing Psirenity to commit itself even further to developing its unique Science of Peace of Mind,” said McCullough.